RYMGX Mutual Fund (S&P MidCap 400 Pure Growth Fund Class A) is managed by Guggenheim Investments with $7.6M in net assets. RYMGX expense ratio is 1.54%, holding 97 positions across sectors including Health Care, Unknown, Industrials. Inception date: 2004-09-01.

RYMGX performance shows a YTD return of 19.84%. The 1-year return is 30.80% and the 5-year return is 13.25%.

RYMGX top holdings include TECHNIPFMC PLC COMMON STOCK (1.8%), Valaris Plc (1.8%), Arrowhead Pharmaceuticals Inc (1.6%), Woodward Inc (1.5%), Mastec Inc (1.5%). View all RYMGX holdings, sector breakdown, or dividend history.

RYMGX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYMGX alternatives are available via the screener, along with tax-loss harvesting opportunities.